Investigators evaluated the long-term neurological, neurocognitive, social, and quality of life outcomes associated with posterior fossa syndrome among survivors of medulloblastoma.

Dosing of Cohort 1 complete with first three patients having received starting dose of JAG201 delivered via ...

Texas Attorney General Ken Paxton issued an opinion that says that a 2023 law that bans gender-transitioning medical care to ...

Science X is a network of high quality websites with most complete and comprehensive daily coverage of the full sweep of science, technology, and medicine news ...

The Weekly Notable Startup Funding Report takes us on a trip across various ecosystems in the US, highlighting some of the notable funding activity in the various markets that we track. The notable ...

In the Phase 2 S-OLARIS clinical trial in axial spondyloarthritis (axSpA), sonelokimab (SLK) demonstrated clinically meaningful benefit with 80+% ...

Six of Australia’s eight states and territories have refused to release any data on the number of children prescribed puberty blockers to treat gender dysphoria, maintaining a veil of secrecy that ...

The U.S. Air Force updated its physical fitness assessment and its accompanying score charts to encourage airmen to utilize ...

Nationwide Children’s Hospital in Columbus, Ohio, has started checking literacy skills during pediatric visits for kids as young as 3.

Physical therapy is a key step on the path to recovery after injuries or certain surgical procedures. A new survey by The Ohio State University Wexner Medical Center shows 3 out of 4 (76%) patients ...

ENHERTU Granted Priority Review in the U.S. as Post-Neoadjuvant Treatment for Patients with HER2 Positive Early Breast Cancer ...

AstraZeneca and Daiichi Sankyo’s supplemental Biologics License Application (sBLA) for ENHERTU® (fam-trastuzumab deruxtecan-nxki) has been accepted and granted Priority Review in the US for the ...